Charles Schwab
TYRA icon

Charles Schwab’s Tyra Biosciences TYRA Stock Holding History

Charles Schwab’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.55M Buy
267,699
+68,588
+34% +$2.27M ﹤0.01% 2231
2026
Q1 		$7.63M Sell
199,111
-315
-0.2% -$10.2K ﹤0.01% 2221
2025
Q4 		$5.24M Sell
199,426
-2,161
-1% -$39.7K ﹤0.01% 2429
2025
Q3 		$2.82M Buy
201,587
+23,483
+13% +$268K ﹤0.01% 2665
2025
Q2 		$1.7M Buy
178,104
+13,996
+9% +$133K ﹤0.01% 2719
2025
Q1 		$1.53M Sell
164,108
-6,492
-4% -$84K ﹤0.01% 2700
2024
Q4 		$2.37M Sell
170,600
-3,137
-2% -$56.9K ﹤0.01% 2622
2024
Q3 		$4.08M Buy
173,737
+3,792
+2% +$79.6K ﹤0.01% 2472
2024
Q2 		$2.72M Buy
169,945
+17,733
+12% +$305K ﹤0.01% 2594
2024
Q1 		$2.5M Buy
152,212
+41,675
+38% +$683K ﹤0.01% 2534
2023
Q4 		$1.53M Buy
110,537
+323
+0.3% +$4.18K ﹤0.01% 2691
2023
Q3 		$1.52M Buy
110,214
+5,557
+5% +$82.4K ﹤0.01% 2672
2023
Q2 		$1.78M Buy
104,657
+2,287
+2% +$33.2K ﹤0.01% 2585
2023
Q1 		$1.65M Buy
102,370
+3,867
+4% +$46K ﹤0.01% 2575
2022
Q4 		$749K Buy
98,503
+2,328
+2% +$16.5K ﹤0.01% 2880
2022
Q3 		$846K Buy
96,175
+14,874
+18% +$136K ﹤0.01% 2840
2022
Q2 		$582K Buy
81,301
+845
+1% +$6.73K ﹤0.01% 3015
2022
Q1 		$861K Buy
80,456
+1,109
+1% +$13.2K ﹤0.01% 2909
2021
Q4 		$1.12M Buy
+79,347
New +$1.58M ﹤0.01% 2866

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Charles Schwab's TYRA Position: Q2 2026 in Review

Charles Schwab increased its Tyra Biosciences (TYRA) stake by 34% in Q2 2026, buying an estimated $2.27M and bringing the position to 267,699 shares worth $8.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2231.

Charles Schwab first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 170 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Charles Schwab held 267,699 shares of Tyra Biosciences worth $8.55M as of Q2 2026.
  • Charles Schwab bought 68,588 Tyra Biosciences shares in Q2 2026, an estimated $2.27M.
  • Tyra Biosciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2231 holding.
  • Charles Schwab first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 170 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.